NCT06862219 2026-03-06A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial CancerAstellas Pharma IncPhase 4 Recruiting100 enrolled
NCT05723991 2023-02-13Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial CarcinomaTongji HospitalPhase 4 Unknown36 enrolled